JSI Awarded Major HRSA Contract to Scale Self-Measured Blood Pressure Integration and Combat the National Hypertension Crisis

High blood pressure remains one of the most pervasive public health challenges in the United States, serving as a primary driver for cardiovascular disease, stroke, kidney failure, and preventable mortality. To address this crisis, JSI has been awarded a significant contract by the Health Resources and Services Administration (HRSA) to expand and accelerate the adoption of Self-Measured Blood Pressure (SMBP) monitoring. The initiative aims to seamlessly integrate SMBP into routine hypertension care across HRSA-funded health centers nationwide, targeting vulnerable patient populations who bear the heaviest burden of chronic cardiovascular conditions.

The Scope of the National Hypertension Crisis

According to recent data from the Centers for Disease Control and Prevention (CDC), an estimated 119.9 million adults in the United States suffer from high blood pressure, clinically defined as hypertension. Despite widespread medical awareness and pharmacological advancements, fewer than one in four of these individuals have their condition under control. This lack of control has devastating public health consequences, contributing directly to more than 660,000 deaths annually in the United States alone.

Hypertension is frequently characterized in the medical community as a silent killer because it often presents no symptoms until catastrophic vascular damage occurs. Over time, persistently elevated arterial pressure strains the heart, accelerates atherosclerosis, damages delicate blood vessels in the brain and kidneys, and significantly increases the risk of myocardial infarctions and cerebrovascular accidents. Beyond the immense human toll, the economic burden of uncontrolled hypertension costs the U.S. healthcare system tens of billions of dollars annually in direct medical expenses, emergency department visits, inpatient admissions, and lost productivity.

Disparities in Hypertension Control Among Vulnerable Populations

While the national statistics regarding hypertension are alarming, the burden is not distributed evenly across the American populace. Deep socio-economic and geographic disparities continue to dictate health outcomes, particularly for patients receiving care in federally qualified health centers and community clinics.

Data indicates that more than 1.8 million patients served by HRSA-funded health centers currently live with uncontrolled hypertension. The highest concentrations of this uncontrolled disease are disproportionately found in rural communities, where geographic isolation, a shortage of primary care providers, and limited access to specialized services hinder continuous disease management. Similarly, low-income households face severe systemic barriers, including food insecurity, lack of reliable transportation, and the financial strains of purchasing home medical devices or paying for recurring medication refills.

Nationwide, community health centers serve a vital role in the healthcare safety net, caring for one in seven primary care patients across the United States. This includes approximately one-quarter of all Medicaid beneficiaries and one-fifth of rural residents. Because these health centers operate with a patient-directed orientation and rely heavily on multidisciplinary, team-based care models, they are uniquely positioned to influence hypertension control rates at both the individual clinical level and the broader population level.

Insights from Clinical Leadership

Addressing the stubborn gap in chronic disease management requires innovative, patient-centered interventions that extend beyond the traditional clinical encounter. Emma Ansara, JSI’s SMBP Clinical and Quality Improvement Co-Lead, emphasizes the urgent need for targeted action within the nation’s health center network.

"While health centers are doing substantial work to support patients with chronic diseases, 31% of health center patients have yet to achieve control of their hypertension," Ansara stated. "This project is about improving hypertension control and preventing associated complications, such as chronic kidney disease."

Ansara’s assessment highlights the multi-organ damage associated with prolonged hypertension. Chronic kidney disease, in particular, shares a closely intertwined pathological relationship with high blood pressure, which gradually destroys the microvasculature of the renal glomeruli. By achieving earlier and more consistent blood pressure control through home monitoring, clinicians hope to halt or significantly slow the progression of renal failure, thereby reducing the reliance on dialysis and mitigating long-term morbidity.

The Evolution of HRSA Initiatives and the Accelerating SMBP Integration Project

The newly announced contract builds upon a foundation of previous federal efforts to curb cardiovascular disease. Notably, HRSA’s National Hypertension Control Initiative (NHCI) demonstrated conclusively that participating health centers could substantially improve blood pressure control rates by systematically integrating SMBP monitoring into their routine clinical workflows and team-based care models.

Building on the lessons learned from the NHCI and prior federal health initiatives, the new project is officially titled Accelerating SMBP Integration to Control, operating under the broader banner of Accelerating Chronic Disease Management Through SMBP and Community Wellness. To execute this complex, multi-faceted initiative, JSI has entered into a strategic partnership with Arbor Research, a renowned organization specializing in health policy research, clinical data analysis, and quality improvement evaluation.

The collaborative project will provide structured virtual technical assistance, practical implementation resources, and rigorous evaluation support to an initial cohort of 30 to 50 participating HRSA-funded health centers. By narrowing the focus to this dedicated cohort, the project team can deliver intensive, customized guidance to address site-specific operational challenges.

Drawing on Decades of Public Health and Health IT Experience

The operational strategy of the new project is firmly anchored in JSI’s extensive institutional history. JSI brings to the partnership a robust track record of implementing more than 100 primary care-focused health projects globally and domestically. Furthermore, the organization leverages 11 years of specialized experience providing national technical assistance through the Health Information Technology, Evaluation, and Quality (HITEQ) Center.

Through the HITEQ Center, JSI has long supported health centers in navigating the complexities of health information technology (IT) adoption. This includes conducting comprehensive assessments of digital tools, evaluating electronic health record (EHR) integration, and ensuring data interoperability between home-based monitoring devices and clinical documentation systems. For SMBP to be clinically effective, blood pressure readings taken by patients at home must be transmitted securely, recorded accurately within the patient’s medical chart, and reviewed efficiently by the clinical care team. JSI’s expertise in health IT infrastructure will be instrumental in overcoming technical barriers that often impede digital health adoption in resource-constrained community settings.

Core Components of the Implementation Strategy

The JSI and Arbor Research team will deploy a comprehensive, evidence-based technical assistance framework designed to embed SMBP permanently into daily primary care workflows. Rather than treating home monitoring as a peripheral or optional activity, the project seeks to transform institutional culture and clinical practice.

Key priorities of the technical assistance program include:

  • Strengthening overall health center capacity for sustained hypertension control and clinical quality improvement.
  • Fostering robust team-based care models that clearly define the roles of physicians, nurse practitioners, nurses, medical assistants, and community health workers in reviewing and acting upon SMBP data.
  • Enhancing patient engagement and health literacy, ensuring that patients understand how to properly measure their blood pressure, interpret their readings, and adhere to prescribed treatment regimens.
  • Developing and distributing practical, user-friendly implementation tools that administrative and clinical staff can readily adopt.

Complementary Community Wellness Integration

Recognizing that clinical intervention alone cannot fully resolve the social and environmental determinants of chronic disease, the project incorporates a holistic approach to patient wellness. Participating health centers will be supported in introducing or expanding community wellness activities tailored to the needs of their local populations.

These complementary strategies may include provider-led walking programs, community-based nutrition education workshops, and partnerships with local organizations to improve access to healthy, affordable food. By addressing lifestyle factors alongside clinical monitoring, the project aims to create a supportive community ecosystem that reinforces medical advice and encourages sustainable behavioral changes among patients managing chronic conditions.

Implications and Long-Term Outlook for the U.S. Healthcare System

The launch of this initiative represents a critical step forward in the national effort to modernize chronic disease management. By formalizing and scaling the integration of Self-Measured Blood Pressure monitoring within the nation’s safety-net health centers, the project addresses the shortcomings of traditional, office-bound blood pressure measurements, which are frequently skewed by "white-coat syndrome" or fail to capture fluctuating daily readings.

Ultimately, the successful execution of the JSI and HRSA partnership is expected to yield multiple measurable benefits. Clinically, it will empower patients to take an active role in managing their own health while providing physicians with accurate, longitudinal data necessary for precise medication titration. Systemically, it will alleviate the immense financial and operational strain that uncontrolled cardiovascular disease places on hospitals and emergency departments. By establishing a scalable, evidence-based framework for long-term hypertension control, this initiative holds the promise of transforming cardiovascular care delivery across the United States, saving countless lives, and reducing preventable health disparities for generations to come.